Benutzer: Gast  Login
Titel:

A systematic review of moral reasons on orphan drug reimbursement.

Dokumenttyp:
Journal Article; Research Support, Non-U.S. Gov't; Review
Autor(en):
Zimmermann, Bettina M; Eichinger, Johanna; Baumgartner, Matthias R
Abstract:
BACKGROUND: The number of market approvals of orphan medicinal products (OMPs) has been increasing steadily in the last 3 decades. While OMPs can offer a unique chance for patients suffering from rare diseases, they are usually very expensive. The growing number of approved OMPs increases their budget impact despite their low prevalence, making it pressing to find solutions to ethical challenges on how to fairly allocate scarce healthcare resources under this context. One potential solution coul...     »
Zeitschriftentitel:
Orphanet J Rare Dis
Jahr:
2021
Band / Volume:
16
Heft / Issue:
1
Volltext / DOI:
doi:10.1186/s13023-021-01925-y
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/34193232
Print-ISSN:
1750-1172
TUM Einrichtung:
Institut für Geschichte und Ethik der Medizin
 BibTeX